688217 logo

Shanghai Rightongene Biotechnology Co., Ltd. Stock Price

SHSE:688217 Community·CN¥1.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688217 Share Price Performance

CN¥26.83
5.98 (28.68%)
CN¥26.83
5.98 (28.68%)
Price CN¥26.83

688217 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

1 Risk
2 Rewards

Shanghai Rightongene Biotechnology Co., Ltd. Key Details

CN¥191.8m

Revenue

CN¥54.4m

Cost of Revenue

CN¥137.4m

Gross Profit

CN¥164.5m

Other Expenses

-CN¥27.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.49
71.63%
-14.14%
0%
View Full Analysis

About 688217

Founded
2012
Employees
385
CEO
Shangxian Gao
WebsiteView website
www.rightongene.com

Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases in China. The company offers self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma. Shanghai Rightongene Biotechnology Co., Ltd. was founded in 2012 and is based in Shanghai, China.

Recent 688217 News & Updates

Recent updates

No updates